Weihrauch > Weihrauchforschung

Literatur zum Thema Weihrauch

Im Folgenden finden Sie ausgewählte Literaturangaben zum Thema Weihrauch. Weitere Literaturangaben bzw. Studien finden Sie auf der unabhängigen Informationsplattform www.weihrauch.org.

Gerne können Sie uns auch kontaktieren: info@aureliasan.de

Eine Auswahl

  • Weihrauch Literatur zum Thema Analytik
    1. Paul, M. Efficient preparation of incensole and incensole acetate, and quantification of these bioactive diterpenes in Boswellia papyrifera by a RP-DAD-HPLC method. Nat. Prod. Commun. 2012 Mar; 7 (3):283-8
    2. Paul, M. A thin-layer chromatography method for the identification of three different olibanum resins (Boswellia serrata, Boswellia papyrifera and Boswellia carterii, respectively, Boswellia sacra). Phytochem. Anal. 2012 Mar-Apr; 23 (2): 184-9
  • Weihrauch Literatur zum Thema Entzündung
    1. Henkel, A. Boswellic acids from frankincense inibit lipopolysaccharide functionality through direct molecular interference. Biochem. Pharmacol. 2012 Jan; 83 (1): 115-21
    2. Siemoneit, U. Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. British Journal of Pharmacology 2011 Jan; 162(1); 147-162
    3. Tausch, L. Identification of human Cathepsin G as a functional target of boswellic acids from anti-inflammatory remedy frankincense. J. Immunol. 2009 Sep. 1; 183 (5): 3433-42
    4. Siemoneit, U. On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance. Eur. J. Pharmacol. 2009 Mar 15; 606 (1-3): 246-54
    5. Siemoneit, U. Identification and functional analysis of Cyclooxygenase-1 as a molecular target of boswellic acids. Biochem. Pharmacol. 2008 Jan 15; 75 (2): 503-13
    6. Chrubasik, JE. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother Res. 2007 Jul; 21 (7):675-83.
    7. Chrubasik, JE. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother Res. 2007 Jul; 21 (7):675-83.
    8. Mee, JB. The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol. 2007 Jul; 171 (1):32-42.
    9. Yoo, H. Insulin-like growth factor-II regulates the 12-lipoxygenase gene expression and promotes cell proliferation in human keratinocytes via the extracellular regulatory kinase and phosphatidylinositol 3-kinase pathways. Int J Biochem Cell Biol. 2007; 39 (6):1248-59.
    10. Ammon, HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006 Oct; 72(12):1100-16.
    11. Banno, N. Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J Ethnopharmacol. 2006 Sep 19; 107 (2):249-53.
    12. Anthoni, C. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2006 Jun; 290 (6):G1131-7.
    13. Poeckel, D. Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase, Mol Pharmacol. 2006, 70, 1071-1078
    14. Poeckel, D. Boswellic acids: biological actions and molecular targets (Invited Review). Current Med Chem. 2006, 28, 3359-3369
    15. Takada, Y. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol. 2006 Mar 1;176(5):3127-40
    16. Poeckel, D. Induction of central signaling pathways and select functional effects in human platelets by ß-boswellic acid. Br. J. Pharmacol. 2005, 146, 514-524.
    17. Chevrier, MR. Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro. Clin Diagn Lab Immunol. 2005 May; 12 (5):575-80.
    18. Reichling, J. Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. Schweiz Arch Tierheilkd. 2004 Feb; 146 (2):71-9.
    19. Altmann, A. Coupling of boswellic acid-induced Ca2+-mobilization and MAPK activation to lipid metabolism and peroxide formation in human leukocytes. Br J Pharmacol. 2004, 141, 223-232
    20. Kimmatkar, N. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial. Phytomedicine. 2003 Jan; 10 (1):3-7.
    21. Altmann, A. Boswellic acids activate p42MAPK and p38 MAPK and stimulate the mobilisation of calcium. Biochem Biophys Res Commun. 2002, 190, 185-190.
    22. Ammon, H. P. [Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases]. Wien Med Wochenschr. 2002; 152 (15-16):373-8.
    23. Huang, MT. Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid. Biofactors. 2000; 13 (1-4):225-30.
    24. Gupta, I. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998 Nov 17;3(11):511-4
    25. Sander, O. [Is H15 (resin extract of Boswellia serrata, "incense") a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study]. Z Rheumatol. 1998 Feb; 57 (1):11-6.
    26. Duwiejua, M. Anti-inflammatory activity of resins from some species of the plant family Burseraceae. Planta Med. 1993 Feb; 59 (1):12-6.
    27. Singh, GB. Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions. 1986 Jun; 18 (3-4):407-12.
  • Übersichtspublikationen zu Weihrauch
    1. Abdel-Tawab, M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin. Pharmacokinet. 2011 Jun; 50 (6): 349-69